Overcoming challenges and embracing innovation in biopharmaceutical manufacturing
The article is based on a podcast and interview with Janet Hoogstraate in March 2025. The biopharmaceutical industry is evolving...
Read the articlePodcast with investor Ted Fjällman
NorthX Biologics’ investor and CEO of Flerie, Ted Fjällman made a guest appearance in a recent episode of Värdeskaparna, a...
Read the articleQ podden with CEO Janet Hoogstraate
Janet Hoogstraate, the CEO of NorthX Biologics, recently appeared in an episode of Q-podden, a podcast on manufacturing, quality and corporate...
Read the articleQ podden with CQO Thomas Beck
Thomas Beck, the Chief Quality Officer (CQO) at NorthX Biologics, was recently featured in an episode of Q podden, a podcast...
Read the articleNavigating Novo Nordisk’s acquisition of Catalent
In this episode of the Molecule to Market podcast, NorthX Biologics CEO Janet Hoogstraate was invited to discuss the implications...
Read the articleNavigating the regulatory and manufacturing realities of mRNA therapeutic development
The increasingly dynamic and multifaceted landscape of mRNA therapeutics is posing new regulatory and manufacturing challenges. Both startups and established...
Read the article